List of insiders holdings for Akari Therapeutics Plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Huh Hoyoung Director 10% Owner | 2026-03-04 16:44:32 | 18,199,697,667 0 | 18,199,697,667 | Form 13G |
| 2 | Patel Samir Rashmikant Director 10% Owner | 2026-03-04 16:44:49 | 9,725,215,000 0 | 9,725,215,000 | Form 13D |
| 3 | Prudo-Chlebosz Raymond Director | 2026-03-04 16:52:44 | 8,391,326,467 0 | 8,391,326,467 | Form 13D |
| 4 | Jacques Rachelle Suzanne Chief Executive Officer | 2024-04-30 21:45:06 | 1,018,027,792 0 | 1,018,027,792 | Form 4 |
| 5 | DICICCO WENDY F Interim CFO | 2024-05-03 16:46:49 | 158,473,915 0 | 158,473,915 | Form 4 |
| 6 | Roshwalb Gur Chief Executive Officer | 2015-09-22 17:41:11 | 32,543,700 0 | 32,543,700 | Form 4 |
| 7 | Richardson Clive COO | 2015-09-23 10:43:36 | 16,271,850 0 | 16,271,850 | Form 4 |
| 8 | Grissinger Michael Director | 2024-07-02 16:30:11 | 5,000,000 0 | 5,000,000 | Form 4 |
| 9 | Hashad Mohamed Wa'el Ahmed Director | 2024-07-02 16:30:06 | 5,000,000 0 | 5,000,000 | Form 4 |
| 10 | WILLIAMS DONALD A Director | 2024-07-02 16:30:05 | 5,000,000 0 | 5,000,000 | Form 4 |
| 11 | Elefant Dov Chief Financial Officer | 2015-09-22 17:42:00 | 4,067,963 0 | 4,067,963 | Form 4 |
| 12 | Williams Donald Allen Director | 2016-06-30 17:08:35 | 2,600,000 0 | 2,600,000 | Form 4 |
| 13 | Gaslightwala Abizer CEO | 2025-12-18 21:56:14 | 2,165,302 0 | 2,165,302 | Form 4 |
| 14 | SHAW ROBERT M General Counsel and Secretary | 2016-03-25 16:16:21 | 1,800,000 0 | 1,800,000 | Form 4 |
| 15 | Hill James Director | 2016-06-30 17:10:02 | 1,300,000 0 | 1,300,000 | Form 4 |
| 16 | Cohen Mark S Director | 2016-06-30 17:11:39 | 1,300,000 0 | 1,300,000 | Form 4 |
| 17 | Byrne David Director | 2016-06-30 17:10:46 | 1,300,000 0 | 1,300,000 | Form 4 |
| 18 | Ungar Stuart Director | 2016-06-30 17:09:27 | 1,300,000 0 | 1,300,000 | Form 4 |
| 19 | Shaw Allan Director | 2015-11-25 18:57:43 | 1,068,722 0 | 1,068,722 | Form 4 |
| 20 | Patel Sandip I Director | 2025-12-18 21:57:24 | 804,252 0 | 804,252 | Form 4 |
| 21 | Hombeck Torsten CFO | 2025-03-24 17:00:10 | 500,200 0 | 500,200 | Form 4 |
| 22 | SIDRANSKY DAVID Director | 2015-01-02 06:10:35 | 440,709 0 | 440,709 | Form 3 |
| 23 | Bazemore Robert B Director | 2025-12-18 21:56:12 | 309,326 0 | 309,326 | Form 4 |
| 24 | LAU JOHNSON YIU NAM Director | 2015-01-02 06:16:12 | 263,250 0 | 263,250 | Form 3 |
| 25 | Jimenez Pablo Chief Medical Officer | 2015-01-02 06:13:35 | 200,000 0 | 200,000 | Form 3 |
| 26 | Doman Robert F Director | 2015-01-02 06:08:41 | 140,000 0 | 140,000 | Form 3 |
| 27 | EIRAN AMOS Director | 2015-01-02 06:06:38 | 135,000 0 | 135,000 | Form 3 |
| 28 | Farag Kameel D. Interim CFO | 2025-12-18 21:57:09 | 49,490 0 | 49,490 | Form 4 |
| 29 | Neal James R Director | 2026-03-16 17:00:03 | 11,132 0 | 11,132 | Form 4 |
| 30 | RPC Pharma Ltd 10% Owner | 2024-06-20 07:30:07 | 0 0 | 0 | Form 13D |
| 31 | SABBY MANAGEMENT LLC Sabby Healthcare Volatility Master Fund Ltd. Mintz Hal 10% Owner | 2016-01-08 15:44:45 | 0 0 | 0 | Form 13G |